Adenosine deaminase Monoclonal Antibody

$Lane 1: CEM cell lysates; Lane 2: Jurkat cell lysates probed with Adenosine deaminase Monoclonal Antibody, Unconjugated (bsm-51538M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.$

Lane 1: CEM cell lysates; Lane 2: Jurkat cell lysates probed with Adenosine deaminase Monoclonal Antibody, Unconjugated (bsm-51538M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Applications

Predicted Reactivity

Human

Overview
Catalog #	bsm-51538M
Product Name	Adenosine deaminase Monoclonal Antibody
Applications	WB
Predicted Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Mouse
Source	KLH conjugated synthetic peptide derived from human Adenosine deaminase
Immunogen Range	231-330/363
Clonality	Monoclonal
Clone #	C55F1
Isotype	IgG1
Concentration	0.5ug/ul
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	100
Swiss Prot	P00813
Subcellular location	Extracellular, Cytoplasm, Cell membrane
Synonyms	ADA; ADA1; ADA_HUMAN; Adenosine aminohydrolase;
Background	Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine. Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, and so contributes indirectly to cellular signaling events. Acts as a positive regulator of T-cell coactivation, by binding DPP4. Its interaction with DPP4 regulates lymphocyte-epithelial cell adhesion.
Application Dilution
WB	=1:500-1000Ôºå